LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,731,964 | -20.3% | 145,727 | -4.0% | 0.00% | 0.0% |
| Q2 2023 | $10,949,721 | -1.5% | 151,869 | +0.5% | 0.00% | 0.0% |
| Q1 2023 | $11,116,427 | +6.1% | 151,121 | -3.6% | 0.00% | 0.0% |
| Q4 2022 | $10,476,412 | -25.1% | 156,833 | -3.5% | 0.00% | -33.3% |
| Q3 2022 | $13,996,000 | -4.7% | 162,545 | -1.3% | 0.00% | 0.0% |
| Q2 2022 | $14,692,000 | -29.0% | 164,662 | -10.5% | 0.00% | -25.0% |
| Q1 2022 | $20,705,000 | -30.1% | 184,068 | -4.0% | 0.00% | -20.0% |
| Q4 2021 | $29,605,000 | +12.7% | 191,665 | +1.6% | 0.01% | 0.0% |
| Q3 2021 | $26,277,000 | +5.4% | 188,614 | -0.7% | 0.01% | 0.0% |
| Q2 2021 | $24,923,000 | -9.5% | 189,976 | +5.2% | 0.01% | -16.7% |
| Q1 2021 | $27,528,000 | +40.4% | 180,580 | -8.4% | 0.01% | +50.0% |
| Q4 2020 | $19,601,000 | -1.5% | 197,104 | -5.5% | 0.00% | -20.0% |
| Q3 2020 | $19,890,000 | -20.1% | 208,651 | -6.2% | 0.01% | -28.6% |
| Q2 2020 | $24,883,000 | +46.4% | 222,464 | -4.8% | 0.01% | +16.7% |
| Q1 2020 | $17,002,000 | -38.8% | 233,790 | -12.3% | 0.01% | -14.3% |
| Q4 2019 | $27,802,000 | -7.2% | 266,585 | -11.4% | 0.01% | -12.5% |
| Q3 2019 | $29,952,000 | -23.5% | 300,912 | -12.3% | 0.01% | -27.3% |
| Q2 2019 | $39,162,000 | -9.6% | 343,072 | -0.5% | 0.01% | -8.3% |
| Q1 2019 | $43,342,000 | -21.6% | 344,776 | -15.4% | 0.01% | -29.4% |
| Q4 2018 | $55,275,000 | -59.6% | 407,336 | -18.2% | 0.02% | -51.4% |
| Q3 2018 | $136,758,000 | +28.2% | 498,228 | -3.2% | 0.04% | +20.7% |
| Q2 2018 | $106,647,000 | +24.3% | 514,777 | -0.9% | 0.03% | +20.8% |
| Q1 2018 | $85,795,000 | +19.0% | 519,465 | -1.3% | 0.02% | +26.3% |
| Q4 2017 | $72,081,000 | +0.6% | 526,411 | -0.0% | 0.02% | -5.0% |
| Q3 2017 | $71,683,000 | +5.4% | 526,499 | -6.0% | 0.02% | +5.3% |
| Q2 2017 | $68,005,000 | +16.2% | 560,181 | +1.3% | 0.02% | +18.8% |
| Q1 2017 | $58,522,000 | +7.9% | 552,936 | +3.6% | 0.02% | 0.0% |
| Q4 2016 | $54,226,000 | +9.4% | 533,670 | +9.9% | 0.02% | +6.7% |
| Q3 2016 | $49,561,000 | -15.1% | 485,614 | -0.7% | 0.02% | -16.7% |
| Q2 2016 | $58,344,000 | -7.6% | 489,176 | -17.1% | 0.02% | -5.3% |
| Q1 2016 | $63,163,000 | +7.1% | 589,823 | +8.4% | 0.02% | +5.6% |
| Q4 2015 | $58,986,000 | +12.6% | 544,054 | -11.1% | 0.02% | +12.5% |
| Q3 2015 | $52,405,000 | -14.5% | 611,853 | +0.7% | 0.02% | -5.9% |
| Q2 2015 | $61,285,000 | +108.1% | 607,384 | +59.0% | 0.02% | +112.5% |
| Q1 2015 | $29,449,000 | +164.5% | 381,890 | +82.5% | 0.01% | +166.7% |
| Q4 2014 | $11,135,000 | +11.1% | 209,252 | -1.9% | 0.00% | 0.0% |
| Q3 2014 | $10,027,000 | -60.6% | 213,399 | -47.8% | 0.00% | 0.0% |
| Q2 2014 | $25,476,000 | +91.4% | 408,968 | +106.7% | 0.00% | -25.0% |
| Q1 2014 | $13,309,000 | +32.3% | 197,842 | +3.5% | 0.00% | +33.3% |
| Q4 2013 | $10,056,000 | +20.3% | 191,169 | -1.1% | 0.00% | +200.0% |
| Q3 2013 | $8,362,000 | +103.5% | 193,202 | +75.8% | 0.00% | 0.0% |
| Q2 2013 | $4,110,000 | – | 109,895 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |